董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Geoffrey S. Martha | 男 | Chairman of the Board and Chief Executive Officer | 53 | 1539.46万美元 | 79.53 | 2023-08-11 |
| Lidia Fonseca | 女 | director | 53 | 29.44万美元 | 0.16 | 2023-08-11 |
| Elizabeth G. Nabel | 女 | director | 71 | 37.00万美元 | 1.37 | 2023-08-11 |
| Andrea J. Goldsmith | 女 | director | 58 | 37.00万美元 | 0.63 | 2023-08-11 |
| Kevin E. Lofton | 男 | director | 68 | 37.00万美元 | 0.42 | 2023-08-11 |
| Gregory P. Lewis | 男 | director | 52 | 未披露 | 未持股 | 2023-08-11 |
| Greg Lewis | 男 | Director | -- | 未披露 | 未持股 | 2023-08-11 |
| Kendall J. Powell | 男 | director | 69 | 35.00万美元 | 4.32 | 2023-08-11 |
| Randall J. Hogan, III | 男 | director | 67 | 38.50万美元 | 4.31 | 2023-08-11 |
| Scott C. Donnelly | 男 | director | 61 | 36.50万美元 | 1.75 | 2023-08-11 |
| Craig Arnold | 男 | Lead Independent Director | 62 | 41.00万美元 | 3.63 | 2023-08-11 |
| Denise M. O'Leary | 女 | director | 65 | 37.50万美元 | 4.65 | 2023-08-11 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Geoffrey S. Martha | 男 | Chairman of the Board and Chief Executive Officer | 53 | 1539.46万美元 | 79.53 | 2023-08-11 |
| Robert J. White | 男 | Executive Vice President and President, Medical Surgical Portfolio | 60 | 503.12万美元 | 62.32 | 2023-08-11 |
| Sean Salmon | 男 | Executive Vice President and President, Cardiovascular Portfolio | 58 | 536.46万美元 | 46.11 | 2023-08-11 |
| Brett Wall | 男 | Executive Vice President and President, Neuroscience Portfolio | 58 | 未披露 | 未持股 | 2023-08-11 |
| Ivan K. Fong | 男 | Executive Vice President, General Counsel and Corporate Secretary | 61 | 1171.62万美元 | 未持股 | 2023-08-11 |
| Gregory L. Smith | 男 | Executive Vice President, Global Operations and Supply Chain | 59 | 未披露 | 未持股 | 2023-08-11 |
| Karen L. Parkhill | 女 | Executive Vice President and Chief Financial Officer | 57 | 612.48万美元 | 50.52 | 2023-08-11 |
| Robert ten Hoedt | 男 | Executive Vice President and President, Global Regions | 62 | 504.77万美元 | 未持股 | 2023-08-11 |
董事简历
中英对照 | 中文 | 英文- Geoffrey S. Martha
-
Geoffrey S. Martha先生，持有宾夕法尼亚州立大（Pennsylvania State University）金融学理学士学位。Martha先生于医疗器械行业拥有逾22年经验，目前为美敦力战略及业务发展高级副总裁。加入美敦力前，Martha先生曾就职于医疗技术及服务供应商通用电气医疗集团，负责该公司的全球业务发展工作。Martha先生先前并无于公司或其任何附属公司担任任何职务。Martha先生于过往三年间并无于上市公众公司担任任何董事职务。于2013年3月12日，获委任为先健科技公司薪酬委员会成员。
Geoffrey S. Martha,is the Chairman of the Board of Directors and Chief Executive Officer of Medtronic. Mr. Martha assumed the role of CEO in April 2020 and became Chairman of the Board in December 2020. Prior to his role as Chairman and CEO, he served as President of Medtronic from November 2019 through April 2020 and joined the Board of Directors in November 2019. Previously, Mr. Martha served as Executive Vice President and President, Restorative Therapies Group, a role he held since August 2015. Mr. Martha previously served as Senior Vice President of Strategy and Business Development of Medtronic plc beginning in January 2015 and of Medtronic, Inc. beginning in August 2011. Prior to that, he served as Managing Director of Business Development at GE Healthcare from April 2007 to July 2011; General Manager for GE Capital Technology Finance Services from November 2003 to March 2007; Senior Vice President, Business Development for GE Capital Vendor Financial Services from February 2002 to October 2003; General Manager for GE Capital Colonial Pacific Leasing from February 2001 to January 2002; and Vice President, Business Development for Potomac Federal, the GE Capital federal financing investment bank from May 1998 to January 2001. - Geoffrey S. Martha先生，持有宾夕法尼亚州立大（Pennsylvania State University）金融学理学士学位。Martha先生于医疗器械行业拥有逾22年经验，目前为美敦力战略及业务发展高级副总裁。加入美敦力前，Martha先生曾就职于医疗技术及服务供应商通用电气医疗集团，负责该公司的全球业务发展工作。Martha先生先前并无于公司或其任何附属公司担任任何职务。Martha先生于过往三年间并无于上市公众公司担任任何董事职务。于2013年3月12日，获委任为先健科技公司薪酬委员会成员。
- Geoffrey S. Martha,is the Chairman of the Board of Directors and Chief Executive Officer of Medtronic. Mr. Martha assumed the role of CEO in April 2020 and became Chairman of the Board in December 2020. Prior to his role as Chairman and CEO, he served as President of Medtronic from November 2019 through April 2020 and joined the Board of Directors in November 2019. Previously, Mr. Martha served as Executive Vice President and President, Restorative Therapies Group, a role he held since August 2015. Mr. Martha previously served as Senior Vice President of Strategy and Business Development of Medtronic plc beginning in January 2015 and of Medtronic, Inc. beginning in August 2011. Prior to that, he served as Managing Director of Business Development at GE Healthcare from April 2007 to July 2011; General Manager for GE Capital Technology Finance Services from November 2003 to March 2007; Senior Vice President, Business Development for GE Capital Vendor Financial Services from February 2002 to October 2003; General Manager for GE Capital Colonial Pacific Leasing from February 2001 to January 2002; and Vice President, Business Development for Potomac Federal, the GE Capital federal financing investment bank from May 1998 to January 2001.
- Lidia Fonseca
-
Lidia Fonseca是Pfizer, Inc.的执行副总裁、首席数字和技术官，负责企业范围的数字、数据和技术战略、产品和解决方案，以及学习和发展和业务流程卓越功能，她自2019年1月以来一直担任该职位。2014年4月至2018年12月，Fonseca女士担任Quest Diagnostics的高级副总裁兼首席信息官。此前，从2008年到2013年，她担任Labcorp的高级副总裁兼首席信息官。她被美国拉丁裔专业人士协会评为2020年和2021年50位最具影响力的拉丁裔人，被医学、营销和媒体评为2020年医疗保健影响者和2019年医疗保健变革者，并获得2017年福布斯CIO创新奖。
Lidia Fonseca,Chief Digital and Technology Officer, Executive Vice President since January 2019. Chief Information Officer and Senior Vice President of Quest Diagnostics Incorporated from 2014 to 2018. Senior Vice President of Laboratory Corporation of America Holdings from 2008 until March 2013. Director of Tegna, Inc. from 2014 to 2023. Director of Medtronic plc. - Lidia Fonseca是Pfizer, Inc.的执行副总裁、首席数字和技术官，负责企业范围的数字、数据和技术战略、产品和解决方案，以及学习和发展和业务流程卓越功能，她自2019年1月以来一直担任该职位。2014年4月至2018年12月，Fonseca女士担任Quest Diagnostics的高级副总裁兼首席信息官。此前，从2008年到2013年，她担任Labcorp的高级副总裁兼首席信息官。她被美国拉丁裔专业人士协会评为2020年和2021年50位最具影响力的拉丁裔人，被医学、营销和媒体评为2020年医疗保健影响者和2019年医疗保健变革者，并获得2017年福布斯CIO创新奖。
- Lidia Fonseca,Chief Digital and Technology Officer, Executive Vice President since January 2019. Chief Information Officer and Senior Vice President of Quest Diagnostics Incorporated from 2014 to 2018. Senior Vice President of Laboratory Corporation of America Holdings from 2008 until March 2013. Director of Tegna, Inc. from 2014 to 2023. Director of Medtronic plc.
- Elizabeth G. Nabel
-
Elizabeth G. Nabel是ModeX Therapeutics公司战略执行副总裁，ModeX Therapeutics公司专注于癌症和传染病的免疫治疗，她于2021年3月开始担任该职位。2010年至2021年2月，Nabel博士担任Brigham Health、医院和医师组织的总裁，经营住院和门诊设施，诊所、初级保健中心、诊断和治疗技术、研究实验室、研究生医学和科学教育及培训项目。从2010年到2021年2月，纳贝尔博士还是哈佛医学院的医学教授。在此之前，Nabel博士担任过多种职务，包括国家卫生研究院国家心脏、肺和血液研究所的主任，国家卫生研究院是一家资助研究、培训和培训的联邦机构，以及1999年至2009年促进心脏病、肺病和血液病预防和治疗的教育计划。Nabel博士是国家科学院国家医学院的当选成员。此外，Nabel博士于2015年至2020年7月在Moderna，Inc.董事会任职，并于2021年3月重新加入Moderna，Inc.董事会。
Elizabeth G. Nabel,is the part-time Medical Advisor of Opko Health, Inc. since June 2023, and the part-time Executive Vice President, Strategy of ModeX Therapeutics, a company focused on immunotherapies for cancer and infectious disease, a position she began in March 2021. From 2010 to February 2021, Dr. Nabel served as the President of Brigham Health, a system including hospitals and physician organizations operating inpatient and outpatient facilities, clinics, primary care health centers, and diagnostic and treatment technologies, research laboratories, and postgraduate medical and scientific education and training programs. Dr. Nabel was also a Professor of Medicine at Harvard Medical School from 2010 to February 2021. Prior to that, Dr. Nabel held a variety of roles, including Director of the National Heart, Lung and Blood Institute at the National Institutes of Health, a federal agency funding research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases, from 1999 to 2009. Dr. Nabel is an elected member of the National Academy of Medicine of the National Academy of Sciences. In addition, Dr. Nabel served on the Board of Directors of Moderna, Inc. from 2015 to July 2020, and re-joined the Moderna Board in March 2021. Dr. Nabel also serves on the Board of Directors of Lyell Immunopharma, Inc., Accolade, Inc. and the Lasker Foundation. - Elizabeth G. Nabel是ModeX Therapeutics公司战略执行副总裁，ModeX Therapeutics公司专注于癌症和传染病的免疫治疗，她于2021年3月开始担任该职位。2010年至2021年2月，Nabel博士担任Brigham Health、医院和医师组织的总裁，经营住院和门诊设施，诊所、初级保健中心、诊断和治疗技术、研究实验室、研究生医学和科学教育及培训项目。从2010年到2021年2月，纳贝尔博士还是哈佛医学院的医学教授。在此之前，Nabel博士担任过多种职务，包括国家卫生研究院国家心脏、肺和血液研究所的主任，国家卫生研究院是一家资助研究、培训和培训的联邦机构，以及1999年至2009年促进心脏病、肺病和血液病预防和治疗的教育计划。Nabel博士是国家科学院国家医学院的当选成员。此外，Nabel博士于2015年至2020年7月在Moderna，Inc.董事会任职，并于2021年3月重新加入Moderna，Inc.董事会。
- Elizabeth G. Nabel,is the part-time Medical Advisor of Opko Health, Inc. since June 2023, and the part-time Executive Vice President, Strategy of ModeX Therapeutics, a company focused on immunotherapies for cancer and infectious disease, a position she began in March 2021. From 2010 to February 2021, Dr. Nabel served as the President of Brigham Health, a system including hospitals and physician organizations operating inpatient and outpatient facilities, clinics, primary care health centers, and diagnostic and treatment technologies, research laboratories, and postgraduate medical and scientific education and training programs. Dr. Nabel was also a Professor of Medicine at Harvard Medical School from 2010 to February 2021. Prior to that, Dr. Nabel held a variety of roles, including Director of the National Heart, Lung and Blood Institute at the National Institutes of Health, a federal agency funding research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases, from 1999 to 2009. Dr. Nabel is an elected member of the National Academy of Medicine of the National Academy of Sciences. In addition, Dr. Nabel served on the Board of Directors of Moderna, Inc. from 2015 to July 2020, and re-joined the Moderna Board in March 2021. Dr. Nabel also serves on the Board of Directors of Lyell Immunopharma, Inc., Accolade, Inc. and the Lasker Foundation.
- Andrea J. Goldsmith
-
Andrea J. Goldsmith于2018年2月被任命为冠城国际公司董事会成员。Goldsmith女士自2020年9月以来一直担任普林斯顿大学工程和应用科学院长以及Arthur Legrand Doty电气和计算机工程教授。从2012年到2020年9月，Goldsmith女士担任斯坦福大学工程学院的Stephen Harris教授，并于1999年1月至2012年担任斯坦福大学的教授，副教授或助理教授。Goldsmith女士还从2010年8月到2014年8月创立Plume WiFi（前身为Accelera，Inc.）并担任首席技术官，从2005年到2009年担任QuantennaCommunications，Inc.（前身为MySource Communications，Inc.）担任首席技术官。此外，Goldsmith女士目前还在Sequans Communications和CoHere Technologies的技术咨询委员会任职。Goldsmith女士经常是有关无线技术的讲师和作家。Goldsmith女士还担任上市公司Medtronic plc的董事会成员。
Andrea J. Goldsmith,serves as the Dean of the School of Engineering and Applied Sciences at Princeton University. Prior to becoming Dean at Princeton, Dr. Goldsmith served as the Stephen Harris Professor in the School of Engineering at Stanford University from 2012-2020 and served as a professor, associate professor or assistant professor of Electrical Engineering at Stanford University since January 1999. Dr. Goldsmith also founded and served as Chief Technology Officer of Plume WiFi (formerly, Accerlera, Inc.) from August 2010 to August 2014 and Quantenna Communications, Inc. (formerly, mySource Communications, Inc.) from 2005 to 2009. In addition, Dr. Goldsmith is a member of the President's Council of Advisers on Science and Technology and currently serves on the Technical Advisory Board of Cohere Technologies. Dr. Goldsmith is a frequent lecturer and writer regarding wireless technologies. - Andrea J. Goldsmith于2018年2月被任命为冠城国际公司董事会成员。Goldsmith女士自2020年9月以来一直担任普林斯顿大学工程和应用科学院长以及Arthur Legrand Doty电气和计算机工程教授。从2012年到2020年9月，Goldsmith女士担任斯坦福大学工程学院的Stephen Harris教授，并于1999年1月至2012年担任斯坦福大学的教授，副教授或助理教授。Goldsmith女士还从2010年8月到2014年8月创立Plume WiFi（前身为Accelera，Inc.）并担任首席技术官，从2005年到2009年担任QuantennaCommunications，Inc.（前身为MySource Communications，Inc.）担任首席技术官。此外，Goldsmith女士目前还在Sequans Communications和CoHere Technologies的技术咨询委员会任职。Goldsmith女士经常是有关无线技术的讲师和作家。Goldsmith女士还担任上市公司Medtronic plc的董事会成员。
- Andrea J. Goldsmith,serves as the Dean of the School of Engineering and Applied Sciences at Princeton University. Prior to becoming Dean at Princeton, Dr. Goldsmith served as the Stephen Harris Professor in the School of Engineering at Stanford University from 2012-2020 and served as a professor, associate professor or assistant professor of Electrical Engineering at Stanford University since January 1999. Dr. Goldsmith also founded and served as Chief Technology Officer of Plume WiFi (formerly, Accerlera, Inc.) from August 2010 to August 2014 and Quantenna Communications, Inc. (formerly, mySource Communications, Inc.) from 2005 to 2009. In addition, Dr. Goldsmith is a member of the President's Council of Advisers on Science and Technology and currently serves on the Technical Advisory Board of Cohere Technologies. Dr. Goldsmith is a frequent lecturer and writer regarding wireless technologies.
- Kevin E. Lofton
-
Kevin E. Lofton，自2019年2月Catholic Health Initiatives和 Dignity Health合并后担任CommonSpirit Health的首席执行官，直到2020年6月退休。从2003年到2019年，Lofton先生担任Catholic Health Initiatives的首席执行官，并从1998年开始担任Catholic Health Initiatives的各种执行管理职务。1993年至1998年，他担任UAB Hospital的执行董事兼首席执行官；1990年至1993年，担任Howard University Hospital的执行董事兼首席执行官；1986年至1990年，担任University Medical Center - Florida的执行副总裁兼首席运营官。此外，他还担任美国医院协会（美国最大的卫生系统贸易协会）的董事会主席。
Kevin E. Lofton,served as the Chief Executive Officer of CommonSpirit Health from February 2019, following the merger between Catholic Health Initiatives and Dignity Health, until his retirement in June 2020. Mr. Lofton previously served as the Chief Executive Officer of Catholic Health Initiatives from 2003 to 2019, and also held various executive management roles with Catholic Health Initiatives beginning in 1998. Mr. Lofton has also served as the Executive Director and Chief Executive Officer from 1993 to 1998 at UAB Hospital and from 1990 to 1993 at Howard University Hospital, as well as the Executive Vice President and Chief Operation Officer of University Medical Center – Florida from 1986 to 1990. In addition, Mr. Lofton served as the 2007 Chairman of the Board of the American Hospital Association, the largest health system trade association in the United States. - Kevin E. Lofton，自2019年2月Catholic Health Initiatives和 Dignity Health合并后担任CommonSpirit Health的首席执行官，直到2020年6月退休。从2003年到2019年，Lofton先生担任Catholic Health Initiatives的首席执行官，并从1998年开始担任Catholic Health Initiatives的各种执行管理职务。1993年至1998年，他担任UAB Hospital的执行董事兼首席执行官；1990年至1993年，担任Howard University Hospital的执行董事兼首席执行官；1986年至1990年，担任University Medical Center - Florida的执行副总裁兼首席运营官。此外，他还担任美国医院协会（美国最大的卫生系统贸易协会）的董事会主席。
- Kevin E. Lofton,served as the Chief Executive Officer of CommonSpirit Health from February 2019, following the merger between Catholic Health Initiatives and Dignity Health, until his retirement in June 2020. Mr. Lofton previously served as the Chief Executive Officer of Catholic Health Initiatives from 2003 to 2019, and also held various executive management roles with Catholic Health Initiatives beginning in 1998. Mr. Lofton has also served as the Executive Director and Chief Executive Officer from 1993 to 1998 at UAB Hospital and from 1990 to 1993 at Howard University Hospital, as well as the Executive Vice President and Chief Operation Officer of University Medical Center – Florida from 1986 to 1990. In addition, Mr. Lofton served as the 2007 Chairman of the Board of the American Hospital Association, the largest health system trade association in the United States.
- Gregory P. Lewis
-
Gregory P. Lewis，他是Honeywell International Inc.的高级副总裁兼首席财务官，自2018年8月以来一直担任该职位。Lewis先生于2006年加入Honeywell，担任前Performance Products业务部门的首席财务官，这是一家快速增长的全球足迹的特种化学品和材料企业。在担任现职之前，Lewis先生曾担任公司财务副总裁，负责财务、税务、审计、业务分析和规划、投资者关系、并购、房地产、养老金、金融运营和企业信息管理（EIM）。此前，他曾担任EIM副总裁；自动化和控制解决方案业务集团副总裁、首席财务官；霍尼韦尔过程解决方案首席财务官；业务分析和规划副总裁。
Gregory P. Lewis,is the Senior Vice President and Chief Financial Officer of Honeywell International Inc., a position he has held since August 2018. Mr. Lewis joined Honeywell in 2006 as Chief Financial Officer of the former Performance Products business unit, a specialty chemicals and materials enterprise with a rapidly growing global footprint. Prior to his current role, Mr. Lewis was Vice President of Corporate Finance, where he led Treasury, Tax, Audit, Business Analysis and Planning, Investor Relations, M&A, Real Estate, Pension, Finance Operations and Enterprise Information Management (EIM). Formerly, he was Vice President, EIM; Vice President, Chief Financial Officer of the Automation and Control Solutions business group; Chief Financial Officer of Honeywell Process Solutions; and Vice President, Business Analysis and Planning. - Gregory P. Lewis，他是Honeywell International Inc.的高级副总裁兼首席财务官，自2018年8月以来一直担任该职位。Lewis先生于2006年加入Honeywell，担任前Performance Products业务部门的首席财务官，这是一家快速增长的全球足迹的特种化学品和材料企业。在担任现职之前，Lewis先生曾担任公司财务副总裁，负责财务、税务、审计、业务分析和规划、投资者关系、并购、房地产、养老金、金融运营和企业信息管理（EIM）。此前，他曾担任EIM副总裁；自动化和控制解决方案业务集团副总裁、首席财务官；霍尼韦尔过程解决方案首席财务官；业务分析和规划副总裁。
- Gregory P. Lewis,is the Senior Vice President and Chief Financial Officer of Honeywell International Inc., a position he has held since August 2018. Mr. Lewis joined Honeywell in 2006 as Chief Financial Officer of the former Performance Products business unit, a specialty chemicals and materials enterprise with a rapidly growing global footprint. Prior to his current role, Mr. Lewis was Vice President of Corporate Finance, where he led Treasury, Tax, Audit, Business Analysis and Planning, Investor Relations, M&A, Real Estate, Pension, Finance Operations and Enterprise Information Management (EIM). Formerly, he was Vice President, EIM; Vice President, Chief Financial Officer of the Automation and Control Solutions business group; Chief Financial Officer of Honeywell Process Solutions; and Vice President, Business Analysis and Planning.
- Greg Lewis
-
Greg Lewis， 2006年加入霍尼韦尔，曾在公司担任多个财务领导职务，包括企业财务副总裁和霍尼韦尔自动化与控制解决方案（ACS）部门的首席财务官。刘易斯在卡夫食品开始了他的职业生涯，后来在泰科国际和斯坦利工厂担任职务。他在福特汉姆大学（Fordham University）获得MBA学位，在康涅狄格大学（University of Connecticut）获得金融学士学位。
Greg Lewis,joined Honeywell in 2006 and has held a variety of financial leadership roles across the company, including Vice President of Corporate Finance and CFO of Honeywell's Automation and Control Solutions (ACS) segment. Lewis started his career at Kraft Foods and went on to roles at Tyco International and the Stanley Works. He received his MBA from Fordham University and a bachelor's degree in finance from the University of Connecticut. - Greg Lewis， 2006年加入霍尼韦尔，曾在公司担任多个财务领导职务，包括企业财务副总裁和霍尼韦尔自动化与控制解决方案（ACS）部门的首席财务官。刘易斯在卡夫食品开始了他的职业生涯，后来在泰科国际和斯坦利工厂担任职务。他在福特汉姆大学（Fordham University）获得MBA学位，在康涅狄格大学（University of Connecticut）获得金融学士学位。
- Greg Lewis,joined Honeywell in 2006 and has held a variety of financial leadership roles across the company, including Vice President of Corporate Finance and CFO of Honeywell's Automation and Control Solutions (ACS) segment. Lewis started his career at Kraft Foods and went on to roles at Tyco International and the Stanley Works. He received his MBA from Fordham University and a bachelor's degree in finance from the University of Connecticut.
- Kendall J. Powell
-
Kendall J. Powell，他是通用磨坊公司的董事会主席兼首席执行官。他在1979年加入了通用磨坊公司工作，在1900年担任副总裁之前，已经担任过多种职位。在1996年他成为优诺司公司的总裁，1997年担任大G谷物公司的总裁，1998年通用磨坊公司的总高级副总裁。从1999年到2004年间担任世界谷物伙伴共面波导与雀巢公司的合资企业的首席执行官；在2004年他又回到CPW，被任命为执行副总裁。2006年，他担任通用磨坊公司整体经营责任的总裁和首席运营官；2007年，担任首席执行官；2008年，担任董事会主席。在2007 年到2008年，他是美敦力的董事。
Kendall J. Powell,was Chairman of General Mills, Inc., an international producer, marketer and distributor of cereals, snacks and processed foods, from 2008 until December 2017 and was Chief Executive Officer of General Mills, Inc. from 2007 until June 2017. He was President and Chief Operating Officer of General Mills, Inc. from 2006 to 2007, and became a director of General Mills, Inc. in 2006. He was Executive Vice President and Chief Operating Officer, U.S. Retail from 2005 to 2006; and Executive Vice President of General Mills, Inc. from 2004 to 2005. From 1999 to 2004, Mr. Powell was Chief Executive Officer of Cereal Partners Worldwide, a joint venture of General Mills, Inc. and the Nestle Corporation. Mr. Powell joined General Mills, Inc. in 1979. Mr. Powell is a former director of General Mills, Inc. Mr. Powell is also the past Chair of the University of Minnesota Board of Regents. - Kendall J. Powell，他是通用磨坊公司的董事会主席兼首席执行官。他在1979年加入了通用磨坊公司工作，在1900年担任副总裁之前，已经担任过多种职位。在1996年他成为优诺司公司的总裁，1997年担任大G谷物公司的总裁，1998年通用磨坊公司的总高级副总裁。从1999年到2004年间担任世界谷物伙伴共面波导与雀巢公司的合资企业的首席执行官；在2004年他又回到CPW，被任命为执行副总裁。2006年，他担任通用磨坊公司整体经营责任的总裁和首席运营官；2007年，担任首席执行官；2008年，担任董事会主席。在2007 年到2008年，他是美敦力的董事。
- Kendall J. Powell,was Chairman of General Mills, Inc., an international producer, marketer and distributor of cereals, snacks and processed foods, from 2008 until December 2017 and was Chief Executive Officer of General Mills, Inc. from 2007 until June 2017. He was President and Chief Operating Officer of General Mills, Inc. from 2006 to 2007, and became a director of General Mills, Inc. in 2006. He was Executive Vice President and Chief Operating Officer, U.S. Retail from 2005 to 2006; and Executive Vice President of General Mills, Inc. from 2004 to 2005. From 1999 to 2004, Mr. Powell was Chief Executive Officer of Cereal Partners Worldwide, a joint venture of General Mills, Inc. and the Nestle Corporation. Mr. Powell joined General Mills, Inc. in 1979. Mr. Powell is a former director of General Mills, Inc. Mr. Powell is also the past Chair of the University of Minnesota Board of Regents.
- Randall J. Hogan, III
-
Randall J. Hogan, III，自2001年以来担任首席执行官，2002年担任董事会主席，1999年到2000年担任总裁和首席运营官，1998年到1999年担任Pentair’s电子电气集团的执行副总裁和总裁，1995年到1997年担任Transicold联合技术载体的总裁；1994年到 1995年担任普惠工业汽轮机的副总裁与总经理，1988年到1994年担任通用电气的各种管理岗位，1981 年到1987年担任麦肯锡公司的咨询顾问。
Randall J. Hogan, III,served as Chairman of nVent Electric plc and in the roles of Chairman, Chief Executive Officer, President and Chief Operating Officer of Pentair, Mr. Hogan offers a wealth of management experience and business acumen. Running a public company gave Mr. Hogan front-line exposure to many of the issues facing public companies, particularly on the operational, financial and corporate governance fronts. Mr. Hogan's service on the Board of Directors and Governance Committee of Unisys as well as on the Board of the Federal Reserve Bank of Minneapolis and service as former Chair of the Audit Committee of Covidien plc further augments his range of knowledge, providing experience on which he can draw while serving as a member of the Board and Audit Committee. - Randall J. Hogan, III，自2001年以来担任首席执行官，2002年担任董事会主席，1999年到2000年担任总裁和首席运营官，1998年到1999年担任Pentair’s电子电气集团的执行副总裁和总裁，1995年到1997年担任Transicold联合技术载体的总裁；1994年到 1995年担任普惠工业汽轮机的副总裁与总经理，1988年到1994年担任通用电气的各种管理岗位，1981 年到1987年担任麦肯锡公司的咨询顾问。
- Randall J. Hogan, III,served as Chairman of nVent Electric plc and in the roles of Chairman, Chief Executive Officer, President and Chief Operating Officer of Pentair, Mr. Hogan offers a wealth of management experience and business acumen. Running a public company gave Mr. Hogan front-line exposure to many of the issues facing public companies, particularly on the operational, financial and corporate governance fronts. Mr. Hogan's service on the Board of Directors and Governance Committee of Unisys as well as on the Board of the Federal Reserve Bank of Minneapolis and service as former Chair of the Audit Committee of Covidien plc further augments his range of knowledge, providing experience on which he can draw while serving as a member of the Board and Audit Committee.
- Scott C. Donnelly
-
Scott C. Donnelly， 他担任德事隆公司董事长，总裁兼首席执行官。他在2008年6月加入德事隆并担任执行副总裁兼首席运营官，2009年1月晋升为总裁兼首席营运官，他于2009年10月被任命为董事。他于2010年9月成为德事隆公司的行政总裁，董事会主席。此前，他是通用电气GE公司的航空业务部门总裁和首席执行官，他2005年7月就开始担任这两个职位。GE公司的航空业务部门是商业和军用喷气发动机，组件，集成数字化，电力和机械系统飞机的领先制造商。2005年7月之前，他曾担任GE全球研发高级副总裁，这是世界上最大和最多样化的工业研究组织，其机构分布在美国，印度，中国和德国。他自1989年加入通用电气，担任多个其他管理职位。他2013年加入美敦力公司的董事会。
Scott C. Donnelly,joined Textron in June 2008 as Executive Vice President and Chief Operating Officer and was promoted to President and Chief Operating Officer in January 2009. He was appointed to the Board of Directors in October 2009 and became Chief Executive Officer of Textron in December 2009. In July 2010, Mr. Donnelly was appointed Chairman of the Board of Directors effective September 1, 2010. Previously, Mr. Donnelly was the President and CEO of General Electric Company's Aviation business unit, a position he had held since July 2005. GE's Aviation business unit is a leading maker of commercial and military jet engines and components, as well as integrated digital, electric power and mechanical systems for aircraft. Prior to July 2005, Mr. Donnelly served as Senior Vice President of GE Global Research, one of the world's largest and most diversified industrial research organizations with facilities in the U.S., India, China and Germany and held various other management positions since joining General Electric in 1989. - Scott C. Donnelly， 他担任德事隆公司董事长，总裁兼首席执行官。他在2008年6月加入德事隆并担任执行副总裁兼首席运营官，2009年1月晋升为总裁兼首席营运官，他于2009年10月被任命为董事。他于2010年9月成为德事隆公司的行政总裁，董事会主席。此前，他是通用电气GE公司的航空业务部门总裁和首席执行官，他2005年7月就开始担任这两个职位。GE公司的航空业务部门是商业和军用喷气发动机，组件，集成数字化，电力和机械系统飞机的领先制造商。2005年7月之前，他曾担任GE全球研发高级副总裁，这是世界上最大和最多样化的工业研究组织，其机构分布在美国，印度，中国和德国。他自1989年加入通用电气，担任多个其他管理职位。他2013年加入美敦力公司的董事会。
- Scott C. Donnelly,joined Textron in June 2008 as Executive Vice President and Chief Operating Officer and was promoted to President and Chief Operating Officer in January 2009. He was appointed to the Board of Directors in October 2009 and became Chief Executive Officer of Textron in December 2009. In July 2010, Mr. Donnelly was appointed Chairman of the Board of Directors effective September 1, 2010. Previously, Mr. Donnelly was the President and CEO of General Electric Company's Aviation business unit, a position he had held since July 2005. GE's Aviation business unit is a leading maker of commercial and military jet engines and components, as well as integrated digital, electric power and mechanical systems for aircraft. Prior to July 2005, Mr. Donnelly served as Senior Vice President of GE Global Research, one of the world's largest and most diversified industrial research organizations with facilities in the U.S., India, China and Germany and held various other management positions since joining General Electric in 1989.
- Craig Arnold
-
Craig Arnold 是伊顿公司的董事长兼首席执行官。他于2000年加入伊顿，担任流体动力集团的高级副总裁和集团执行官。他曾担任工业部门的副董事长兼首席运营官（2015年8月），以及总裁兼首席运营官（2016年6月）。他目前任职于Medtronic plc、the Business Roundtable和University Hospitals Health System的董事会。他担任The Greater Cleveland Partnership和United Way of Greater Cleveland的董事。他也是The Business Council和The Salvation Army of Greater Cleveland的顾问委员会成员。
Craig Arnold,has been Chairman and Chief Executive Officer of Eaton Corporation, a multinational power management company, since June 2016. From September 2015 to May 2016, Mr. Arnold served as President and Chief Operating Officer of Eaton Corporation. Prior to that, Mr. Arnold served as the Vice Chairman and Chief Operating Officer, Industrial Sector, of Eaton Corporation. From 2000 to 2008 he served as Senior Vice President of Eaton Corporation and Group Executive of the Fluid Power Group of Eaton. Prior to joining Eaton, Mr. Arnold was employed in a series of progressively more responsible positions at General Electric Company from 1983 to 2000. Mr. Arnold was appointed to the Board of Directors of Eaton Corporation in 2015. Mr. Arnold is a former director of Covidien plc. - Craig Arnold 是伊顿公司的董事长兼首席执行官。他于2000年加入伊顿，担任流体动力集团的高级副总裁和集团执行官。他曾担任工业部门的副董事长兼首席运营官（2015年8月），以及总裁兼首席运营官（2016年6月）。他目前任职于Medtronic plc、the Business Roundtable和University Hospitals Health System的董事会。他担任The Greater Cleveland Partnership和United Way of Greater Cleveland的董事。他也是The Business Council和The Salvation Army of Greater Cleveland的顾问委员会成员。
- Craig Arnold,has been Chairman and Chief Executive Officer of Eaton Corporation, a multinational power management company, since June 2016. From September 2015 to May 2016, Mr. Arnold served as President and Chief Operating Officer of Eaton Corporation. Prior to that, Mr. Arnold served as the Vice Chairman and Chief Operating Officer, Industrial Sector, of Eaton Corporation. From 2000 to 2008 he served as Senior Vice President of Eaton Corporation and Group Executive of the Fluid Power Group of Eaton. Prior to joining Eaton, Mr. Arnold was employed in a series of progressively more responsible positions at General Electric Company from 1983 to 2000. Mr. Arnold was appointed to the Board of Directors of Eaton Corporation in 2015. Mr. Arnold is a former director of Covidien plc.
- Denise M. O'Leary
-
Denise M. O'Leary，2013年12月起，担任本公司董事。1996年以来，她一直是早期阶段公司的个人投资者。1983-1996，她任职于风投公司Menlo Ventures，先后担任初级合伙人、普通合伙人。她目前是医疗技术公司Medtronic Plc、电力批发制造商Calpine Corporation的董事。另外，她还是University of Colorado Hospital Authority、Denver Foundation、Bonfils-Stanton Foundation 、University of Denver的董事。她曾担任下列机构的董事：America West 、AWA，1998-2005；US Airways Group、US Airways，2005年直到2013年12月合并；the Lucile Packard Children’s Hospital，1997-2012；Stanford Hospital & Clinics，1994-2012。
Denise M. O'Leary,has been a private venture capital investor in a variety of early stage companies since 1996. She was a member of the Stanford University Board of Trustees from 1996 through 2006, where she chaired the Committee of the Medical Center. Ms. O'Leary is a former director of US Airways Group, Inc. and Calpine Corporation. In addition, Ms. O'Leary is a member of the Board of Trustees of the University of Denver, where she served as Chair from July 2018 until June 2022. - Denise M. O'Leary，2013年12月起，担任本公司董事。1996年以来，她一直是早期阶段公司的个人投资者。1983-1996，她任职于风投公司Menlo Ventures，先后担任初级合伙人、普通合伙人。她目前是医疗技术公司Medtronic Plc、电力批发制造商Calpine Corporation的董事。另外，她还是University of Colorado Hospital Authority、Denver Foundation、Bonfils-Stanton Foundation 、University of Denver的董事。她曾担任下列机构的董事：America West 、AWA，1998-2005；US Airways Group、US Airways，2005年直到2013年12月合并；the Lucile Packard Children’s Hospital，1997-2012；Stanford Hospital & Clinics，1994-2012。
- Denise M. O'Leary,has been a private venture capital investor in a variety of early stage companies since 1996. She was a member of the Stanford University Board of Trustees from 1996 through 2006, where she chaired the Committee of the Medical Center. Ms. O'Leary is a former director of US Airways Group, Inc. and Calpine Corporation. In addition, Ms. O'Leary is a member of the Board of Trustees of the University of Denver, where she served as Chair from July 2018 until June 2022.
高管简历
中英对照 | 中文 | 英文- Geoffrey S. Martha
Geoffrey S. Martha先生，持有宾夕法尼亚州立大（Pennsylvania State University）金融学理学士学位。Martha先生于医疗器械行业拥有逾22年经验，目前为美敦力战略及业务发展高级副总裁。加入美敦力前，Martha先生曾就职于医疗技术及服务供应商通用电气医疗集团，负责该公司的全球业务发展工作。Martha先生先前并无于公司或其任何附属公司担任任何职务。Martha先生于过往三年间并无于上市公众公司担任任何董事职务。于2013年3月12日，获委任为先健科技公司薪酬委员会成员。
Geoffrey S. Martha,is the Chairman of the Board of Directors and Chief Executive Officer of Medtronic. Mr. Martha assumed the role of CEO in April 2020 and became Chairman of the Board in December 2020. Prior to his role as Chairman and CEO, he served as President of Medtronic from November 2019 through April 2020 and joined the Board of Directors in November 2019. Previously, Mr. Martha served as Executive Vice President and President, Restorative Therapies Group, a role he held since August 2015. Mr. Martha previously served as Senior Vice President of Strategy and Business Development of Medtronic plc beginning in January 2015 and of Medtronic, Inc. beginning in August 2011. Prior to that, he served as Managing Director of Business Development at GE Healthcare from April 2007 to July 2011; General Manager for GE Capital Technology Finance Services from November 2003 to March 2007; Senior Vice President, Business Development for GE Capital Vendor Financial Services from February 2002 to October 2003; General Manager for GE Capital Colonial Pacific Leasing from February 2001 to January 2002; and Vice President, Business Development for Potomac Federal, the GE Capital federal financing investment bank from May 1998 to January 2001.- Geoffrey S. Martha先生，持有宾夕法尼亚州立大（Pennsylvania State University）金融学理学士学位。Martha先生于医疗器械行业拥有逾22年经验，目前为美敦力战略及业务发展高级副总裁。加入美敦力前，Martha先生曾就职于医疗技术及服务供应商通用电气医疗集团，负责该公司的全球业务发展工作。Martha先生先前并无于公司或其任何附属公司担任任何职务。Martha先生于过往三年间并无于上市公众公司担任任何董事职务。于2013年3月12日，获委任为先健科技公司薪酬委员会成员。
- Geoffrey S. Martha,is the Chairman of the Board of Directors and Chief Executive Officer of Medtronic. Mr. Martha assumed the role of CEO in April 2020 and became Chairman of the Board in December 2020. Prior to his role as Chairman and CEO, he served as President of Medtronic from November 2019 through April 2020 and joined the Board of Directors in November 2019. Previously, Mr. Martha served as Executive Vice President and President, Restorative Therapies Group, a role he held since August 2015. Mr. Martha previously served as Senior Vice President of Strategy and Business Development of Medtronic plc beginning in January 2015 and of Medtronic, Inc. beginning in August 2011. Prior to that, he served as Managing Director of Business Development at GE Healthcare from April 2007 to July 2011; General Manager for GE Capital Technology Finance Services from November 2003 to March 2007; Senior Vice President, Business Development for GE Capital Vendor Financial Services from February 2002 to October 2003; General Manager for GE Capital Colonial Pacific Leasing from February 2001 to January 2002; and Vice President, Business Development for Potomac Federal, the GE Capital federal financing investment bank from May 1998 to January 2001.
- Robert J. White
Robert J. White自2017年12月起担任公司微创疗法集团执行副总裁兼总裁。在此之前，他于2015年1月至2017年12月担任亚太地区高级副总裁兼总裁。 Covidien公司新兴市场，呼吸和监测解决方案总裁兼患者监测副总裁兼总经理。 他还曾在GE Healthcare和IBM担任过各种领导职务。 怀特先生还是Smith＆Nephew plc董事会的现任成员。
Robert J. White,is Executive Vice President and President, Medical Surgical Portfolio. Since 2017, Mr. White has served as Executive Vice President and Group President of the Minimally Invasive Therapies Group of Medtronic. Prior to that, he was Senior Vice President and President, Asia Pacific from January 2015 to December 2017. He had served as President, Emerging Markets, President, Respiratory and Monitoring Solutions and Vice President and General Manager of Patient Monitoring at Covidien. He also held various leadership positions at GE Healthcare and IBM. Mr. White is also a current member of the Board of Directors of Smith & Nephew plc.- Robert J. White自2017年12月起担任公司微创疗法集团执行副总裁兼总裁。在此之前，他于2015年1月至2017年12月担任亚太地区高级副总裁兼总裁。 Covidien公司新兴市场，呼吸和监测解决方案总裁兼患者监测副总裁兼总经理。 他还曾在GE Healthcare和IBM担任过各种领导职务。 怀特先生还是Smith＆Nephew plc董事会的现任成员。
- Robert J. White,is Executive Vice President and President, Medical Surgical Portfolio. Since 2017, Mr. White has served as Executive Vice President and Group President of the Minimally Invasive Therapies Group of Medtronic. Prior to that, he was Senior Vice President and President, Asia Pacific from January 2015 to December 2017. He had served as President, Emerging Markets, President, Respiratory and Monitoring Solutions and Vice President and General Manager of Patient Monitoring at Covidien. He also held various leadership positions at GE Healthcare and IBM. Mr. White is also a current member of the Board of Directors of Smith & Nephew plc.
- Sean Salmon
Sean Salmon，自2019年10月以来，Sean Salmon一直担任公司糖尿病集团执行副总裁兼集团总裁。Salmon先生曾于2014年7月开始担任公司心血管集团的高级副总裁兼冠状动脉和结构性心脏业务总裁 Salmon先生是一位经验丰富的领导者，自2004年以来一直在美敦力工作，在过去的16年中一直担任越来越高级的管理职务。在加入美敦力之前，Salmon先生曾在CR Bard和Johnson＆Johnson工作。
Sean Salmon,has been Executive Vice President and President of Medtronic's Cardiovascular Portfolio since January 2021. Mr. Salmon previously served as Executive Vice President and President of the Diabetes Operating Unit (previously known as Diabetes Group) from October 2019 to May 2022. Prior to that, he served as Senior Vice President and President of Coronary and Structural Heart Business within the Cardiac and Vascular Group of the Company beginning in July 2014. Mr. Salmon is a seasoned leader who has been with Medtronic since 2004 and spent the past 16 years in increasingly senior levels of management. Prior to joining Medtronic, Mr. Salmon worked at CR Bard and Johnson & Johnson.within the Cardiac and Vascular Group of the Company beginning in July 2014. Mr. Salmon is a seasoned leader who has been with Medtronic since 2004 and spent the past 16 years in increasingly senior levels of management. Prior to joining Medtronic, Mr. Salmon worked at CR Bard and Johnson & Johnson.- Sean Salmon，自2019年10月以来，Sean Salmon一直担任公司糖尿病集团执行副总裁兼集团总裁。Salmon先生曾于2014年7月开始担任公司心血管集团的高级副总裁兼冠状动脉和结构性心脏业务总裁 Salmon先生是一位经验丰富的领导者，自2004年以来一直在美敦力工作，在过去的16年中一直担任越来越高级的管理职务。在加入美敦力之前，Salmon先生曾在CR Bard和Johnson＆Johnson工作。
- Sean Salmon,has been Executive Vice President and President of Medtronic's Cardiovascular Portfolio since January 2021. Mr. Salmon previously served as Executive Vice President and President of the Diabetes Operating Unit (previously known as Diabetes Group) from October 2019 to May 2022. Prior to that, he served as Senior Vice President and President of Coronary and Structural Heart Business within the Cardiac and Vascular Group of the Company beginning in July 2014. Mr. Salmon is a seasoned leader who has been with Medtronic since 2004 and spent the past 16 years in increasingly senior levels of management. Prior to joining Medtronic, Mr. Salmon worked at CR Bard and Johnson & Johnson.within the Cardiac and Vascular Group of the Company beginning in July 2014. Mr. Salmon is a seasoned leader who has been with Medtronic since 2004 and spent the past 16 years in increasingly senior levels of management. Prior to joining Medtronic, Mr. Salmon worked at CR Bard and Johnson & Johnson.
- Brett Wall
Brett Wall，自2019年11月以来，一直担任美敦力（Medtronic）修复疗法集团的执行副总裁兼总裁。沃尔先生此前曾担任美敦力（Medtronic）的高级副总裁兼脑疗法部门总裁，该部门是美敦力公司修复疗法集团的一部分，自2016年3月开始 在此之前，Wall先生曾担任Medtronic神经血管业务的高级副总裁兼总裁。 在加入美敦力之前，他曾担任Covidien的高级副总裁兼神经血管病总裁，以及Covidien的高级副总裁兼国际血管疗法业务总裁。 Wall先生还曾担任ev3 Inc.的高级副总裁兼国际总裁。从2000年到2008年，Brett分别在ev3 Inc.和Micro Therapeutics，Inc.担任过各种营销和销售职位。 1995年9月至2000年9月，亚太地区心血管市场营销部和日本市场营销经理。
Brett Wall,is Executive Vice President and President of Medtronic's Neuroscience Portfolio. Mr. Wall previously served as Senior Vice President and President of the Brain Therapies division of Medtronic within the Restorative Therapies Group from March 2016 to November 2019. Prior to that, Mr. Wall served as SVP and President of Medtronic's Neurovascular business. Prior to joining Medtronic, he served as Covidien's SVP and President of Neurovascular as well as Senior Vice President and President of the International Vascular Therapies business for Covidien. Mr. Wall also served as Senior Vice President and President, International at ev3, Inc. From 2000 to 2008, Brett held various marketing and sales positions with ev3, Inc. and Micro Therapeutics, Inc. Mr. Wall has also worked at Boston Scientific as Director of Marketing, Cardiovascular, Asia Pacifica and Marketing Manager, Japan, from September 1995 to September 2000.- Brett Wall，自2019年11月以来，一直担任美敦力（Medtronic）修复疗法集团的执行副总裁兼总裁。沃尔先生此前曾担任美敦力（Medtronic）的高级副总裁兼脑疗法部门总裁，该部门是美敦力公司修复疗法集团的一部分，自2016年3月开始 在此之前，Wall先生曾担任Medtronic神经血管业务的高级副总裁兼总裁。 在加入美敦力之前，他曾担任Covidien的高级副总裁兼神经血管病总裁，以及Covidien的高级副总裁兼国际血管疗法业务总裁。 Wall先生还曾担任ev3 Inc.的高级副总裁兼国际总裁。从2000年到2008年，Brett分别在ev3 Inc.和Micro Therapeutics，Inc.担任过各种营销和销售职位。 1995年9月至2000年9月，亚太地区心血管市场营销部和日本市场营销经理。
- Brett Wall,is Executive Vice President and President of Medtronic's Neuroscience Portfolio. Mr. Wall previously served as Senior Vice President and President of the Brain Therapies division of Medtronic within the Restorative Therapies Group from March 2016 to November 2019. Prior to that, Mr. Wall served as SVP and President of Medtronic's Neurovascular business. Prior to joining Medtronic, he served as Covidien's SVP and President of Neurovascular as well as Senior Vice President and President of the International Vascular Therapies business for Covidien. Mr. Wall also served as Senior Vice President and President, International at ev3, Inc. From 2000 to 2008, Brett held various marketing and sales positions with ev3, Inc. and Micro Therapeutics, Inc. Mr. Wall has also worked at Boston Scientific as Director of Marketing, Cardiovascular, Asia Pacifica and Marketing Manager, Japan, from September 1995 to September 2000.
- Ivan K. Fong
Ivan K. Fong，自2020年12月起担任Cboe Global Markets, Inc.董事。他目前担任3M公司的高级副总裁、总法律顾问和秘书（从2019年6月起）。在此之前，从2012年到2019年，他担任3M公司法律事务高级副总裁和总法律顾问。加入3M公司之前，他曾担任美国国土安全部（United States Department of Homeland Security）的总法律顾问（2009年至2012年），以及Cardinal Health, Inc.的首席法律官兼秘书（2005年至2009年）。他持有麻省理工学院化学工程学士学位和化学工程实践硕士学位，斯坦福大学法学博士学位和牛津大学民法学士学位。
Ivan K. Fong,has served on Cboe Global Markets, Inc. Board since December 2020. Mr. Fong is currently Executive Vice President, General Counsel and Secretary of Medtronic plc, a position he has held from February 2022. Prior to this position, he served as Senior Vice President, Chief Legal and Policy Officer and Secretary of 3M Company from 2019 to January 2022 and as its Senior Vice President, Legal Affairs and General Counsel from 2012 to 2019. Prior to joining 3M Company, Mr. Fong was General Counsel of the U.S. Department of Homeland Security from 2009 to 2012 and Chief Legal Officer and Secretary of Cardinal Health, Inc. from 2005 to 2009. He has previously served as Deputy Associate Attorney General with the U.S. Department of Justice and was a partner with the law firm of Covington & Burling LLP. Mr. Fong holds an S.B. degree in Chemical Engineering and an S.M. degree in Chemical Engineering Practice from Massachusetts Institute of Technology, a J.D. degree from Stanford University, and a Bachelor of Civil Law from Oxford University.- Ivan K. Fong，自2020年12月起担任Cboe Global Markets, Inc.董事。他目前担任3M公司的高级副总裁、总法律顾问和秘书（从2019年6月起）。在此之前，从2012年到2019年，他担任3M公司法律事务高级副总裁和总法律顾问。加入3M公司之前，他曾担任美国国土安全部（United States Department of Homeland Security）的总法律顾问（2009年至2012年），以及Cardinal Health, Inc.的首席法律官兼秘书（2005年至2009年）。他持有麻省理工学院化学工程学士学位和化学工程实践硕士学位，斯坦福大学法学博士学位和牛津大学民法学士学位。
- Ivan K. Fong,has served on Cboe Global Markets, Inc. Board since December 2020. Mr. Fong is currently Executive Vice President, General Counsel and Secretary of Medtronic plc, a position he has held from February 2022. Prior to this position, he served as Senior Vice President, Chief Legal and Policy Officer and Secretary of 3M Company from 2019 to January 2022 and as its Senior Vice President, Legal Affairs and General Counsel from 2012 to 2019. Prior to joining 3M Company, Mr. Fong was General Counsel of the U.S. Department of Homeland Security from 2009 to 2012 and Chief Legal Officer and Secretary of Cardinal Health, Inc. from 2005 to 2009. He has previously served as Deputy Associate Attorney General with the U.S. Department of Justice and was a partner with the law firm of Covington & Burling LLP. Mr. Fong holds an S.B. degree in Chemical Engineering and an S.M. degree in Chemical Engineering Practice from Massachusetts Institute of Technology, a J.D. degree from Stanford University, and a Bachelor of Civil Law from Oxford University.
- Gregory L. Smith
Gregory L. Smith，自2021年4月起担任全球运营和供应链执行副总裁。在加入Medtronic之前，他曾担任沃尔玛美国供应链执行副总裁。此外，Smith先生曾担任The Goodyear Tire & Rubber Company的全球运营高级副总裁，并在ConAgra Foods、United Signature Foods、VDK Frozen Foods和Quaker Oats担任领导职务。
Gregory L. Smith,is Executive Vice President, Global Operations and Supply Chain, a position he has held since April 2021. Prior to joining Medtronic, he was Executive Vice President of U.S. Supply Chain at Walmart. In addition, Mr. Smith served as Senior Vice President, Global Operations at The Goodyear Tire & Rubber Company, and held leadership roles at ConAgra Foods, United Signature Foods, VDK Frozen Foods and Quaker Oats.- Gregory L. Smith，自2021年4月起担任全球运营和供应链执行副总裁。在加入Medtronic之前，他曾担任沃尔玛美国供应链执行副总裁。此外，Smith先生曾担任The Goodyear Tire & Rubber Company的全球运营高级副总裁，并在ConAgra Foods、United Signature Foods、VDK Frozen Foods和Quaker Oats担任领导职务。
- Gregory L. Smith,is Executive Vice President, Global Operations and Supply Chain, a position he has held since April 2021. Prior to joining Medtronic, he was Executive Vice President of U.S. Supply Chain at Walmart. In addition, Mr. Smith served as Senior Vice President, Global Operations at The Goodyear Tire & Rubber Company, and held leadership roles at ConAgra Foods, United Signature Foods, VDK Frozen Foods and Quaker Oats.
- Karen L. Parkhill
Karen L. Parkhill，就职于Comerica公司和Comerica银行。2007年9月至2011年3月任J.P. Morgan Chase & Co公司（金融服务公司）常务董事、首席财务官，负责商业银行业务。
Karen L. Parkhill,joined the Company as Executive Vice President and Chief Financial Officer in June 2016. From 2011 to 2016, Ms. Parkhill served as Vice Chairman and Chief Financial Officer of Comerica Incorporated. Ms. Parkhill was a member of Comerica's Management Executive Committee and the Comerica Bank Board of Directors. Prior to joining Comerica, Ms. Parkhill worked for J.P. Morgan Chase & Co. in various capacities from 1992 to 2011, including serving as Chief Financial Officer of the Commercial Banking business from 2007 to 2011. Ms. Parkhill is also a current member of the Board of Directors for American Express.- Karen L. Parkhill，就职于Comerica公司和Comerica银行。2007年9月至2011年3月任J.P. Morgan Chase & Co公司（金融服务公司）常务董事、首席财务官，负责商业银行业务。
- Karen L. Parkhill,joined the Company as Executive Vice President and Chief Financial Officer in June 2016. From 2011 to 2016, Ms. Parkhill served as Vice Chairman and Chief Financial Officer of Comerica Incorporated. Ms. Parkhill was a member of Comerica's Management Executive Committee and the Comerica Bank Board of Directors. Prior to joining Comerica, Ms. Parkhill worked for J.P. Morgan Chase & Co. in various capacities from 1992 to 2011, including serving as Chief Financial Officer of the Commercial Banking business from 2007 to 2011. Ms. Parkhill is also a current member of the Board of Directors for American Express.
- Robert ten Hoedt
Robert ten Hoedt，2015年1月以来，他担任公司的欧洲、中东、非洲执行副总裁和总裁。他担任Medtronic, Inc.的执行副总裁和总裁（2014年5月以来）。此前从2009年到2014年，他曾担任欧洲、中东、非洲和加拿大的高级副总裁和总裁。从2006年到2009年，他担任CardioVascular欧洲和中亚的副总裁。从1999年到2006年，他担任Vitatron的副总裁何总经理。从1994年到1999年，他担任领导人。从1991年到1994年，他担任Neurological市场销售经理。
Robert ten Hoedt,is Executive Vice President and President of the Global Regions. He previously served as Executive Vice President and President, EMEA Region of the Company since January 2015 and of Medtronic, Inc. since May 2014, as well as President, APAC Region since March 2022. Prior to that, he was Senior Vice President and President, EMEA and Canada from 2009 to 2014; Vice President CardioVascular Europe and Central Asia from 2006 to 2009; Vice President and General Manager, Vitatron from 1999 to 2006; Gastro-Uro leader from 1994 to 1999; and Marketing Manager, Neurological from 1991 to 1994.- Robert ten Hoedt，2015年1月以来，他担任公司的欧洲、中东、非洲执行副总裁和总裁。他担任Medtronic, Inc.的执行副总裁和总裁（2014年5月以来）。此前从2009年到2014年，他曾担任欧洲、中东、非洲和加拿大的高级副总裁和总裁。从2006年到2009年，他担任CardioVascular欧洲和中亚的副总裁。从1999年到2006年，他担任Vitatron的副总裁何总经理。从1994年到1999年，他担任领导人。从1991年到1994年，他担任Neurological市场销售经理。
- Robert ten Hoedt,is Executive Vice President and President of the Global Regions. He previously served as Executive Vice President and President, EMEA Region of the Company since January 2015 and of Medtronic, Inc. since May 2014, as well as President, APAC Region since March 2022. Prior to that, he was Senior Vice President and President, EMEA and Canada from 2009 to 2014; Vice President CardioVascular Europe and Central Asia from 2006 to 2009; Vice President and General Manager, Vitatron from 1999 to 2006; Gastro-Uro leader from 1994 to 1999; and Marketing Manager, Neurological from 1991 to 1994.